IR情報

2023/06/14~2023/11/07

IR情報&株価推移

日付始値高値安値終値前日比出来高時価総額25日乖離
2023
11/07461474451468-1.47%608,500306億5797万-13.17%
11/06469478458475+4.17%780,100311億1653万-13%
11/02420458417456+9.35%936,900298億7187万-17.39%
11/01421424408417-0.48%547,200273億1704万-25.4%
10/31418428416419+0.24%489,800274億4806万-26.23%
10/30431438416418-4.13%788,400273億8255万-27.56%
10/27447451435436-2.46%783,000285億6170万-25.72%
10/26468468437447-7.64%1,752,000292億8230万-24.87%
10/25501508483484-1.43%1,119,700317億611万-20%
10/24484495484491-15.92%1,719,500321億6467万-20.03%
10/23599603581584-2.18%375,100379億3506万-6.11%
10/20600603589597-1.16%327,900387億7950万-4.48%
10/19592605591604+1%270,300392億3421万-3.67%
10/18594604589598+0.84%249,100388億4446万-4.78%
10/17598607589593-0.67%290,600385億1968万-5.87%
10/16597598587597+0.17%260,500387億7950万-5.54%
10/13608610593596-2.93%330,300387億1455万-5.85%
10/12612622606614+1.32%200,800398億8378万-3.61%
10/11623623604606-2.42%304,100393億6412万-5.61%
10/10611626604621+2.48%360,300403億3848万-3.42%
10/06587606583606+3.95%306,700393億6412万-5.75%
10/05580593575583+2.1%308,700378億7010万-9.19%
10/04590599571571-4.36%559,800370億9061万-11.06%
10/03606626594597-1.97%462,900387億7950万-7.01%
10/0216:30 行使価額修正条項付新株予約権の月間行使状況に関するお知らせ
10/02635635605609-2.72%380,200395億5899万-5.14%
09/29631643623626-0.79%320,400406億6327万-2.19%
09/28634639628631-1.1%237,900409億8805万-1.1%
09/27622639619638+1.92%378,700414億4275万+0.31%
09/26645645622626-3.84%480,700406億6327万-1.26%
09/25670673647651-1.81%397,600422億8720万+3.17%
09/22657668647663+2.31%393,300430億6669万+5.74%
09/21680681643648-5.95%805,900420億9207万+4.18%
09/20694722687689-2.27%624,200447億5530万+11.49%
09/197077406937050%1,688,800457億9461万+15.01%
09/1515:00 2024年1月期第2四半期決算説明会資料
09/15667710663705+8.96%2,045,400457億9461万+15.95%
09/1415:00 2024年1月期第2四半期累計期間の連結業績予想と実績値との差異に関するお知らせ
09/1415:00 営業外収益及び法人税等調整額の計上に関するお知らせ
09/1415:00 2024年1月期第2四半期決算短信〔日本基準〕(連結)
09/14643651635647-0.31%406,400420億2711万+7.48%
09/13637649635649+0.93%323,500421億5702万+8.35%
09/12629652628643+2.23%455,100417億6728万+7.89%
09/11648648627629-2.93%549,000408億5789万+6.07%
09/08634649628648+2.37%605,500420億9207万+9.64%
09/07650652621633-8.26%1,681,600411億1771万+7.65%
09/06743743686690-4.7%2,985,600448億2026万+17.55%
09/05654729654724+11.38%3,928,500470億2879万+23.97%
09/04632658611650+5.01%1,866,700422億2198万+12.26%
09/01610636604619+9.75%3,253,000402億832万+7.28%
08/3115:00 国内SB623慢性期外傷性脳損傷プログラム製造販売承認取得の状況について(続報)
08/31585586564564-3.26%509,700366億3569万-2.08%
08/30595595582583-2.02%178,000378億6987万+0.87%
08/29578595578595+3.12%449,900386億4935万+2.76%
08/28578588576577+0.17%137,800374億8013万-0.35%
08/25566580564576+1.05%250,300374億1517万-0.69%
08/24577579568570-2.06%220,100370億2543万-1.89%
08/23577592571582+1.39%451,200378億491万0%
08/22564578564574+1.95%277,600372億8526万-1.54%
08/21530566530563+4.84%448,100365億7073万-3.6%
08/18533545527537-1.65%353,500348億8185万-8.21%
08/17552555538546-1.62%551,700354億6646万-6.98%
08/16559561550555-1.77%426,500360億5108万-5.77%
08/15569569557565-0.18%390,600367億64万-4.56%
08/14574580566566-1.74%202,600367億6560万-4.71%
08/10565576564576+1.23%201,400374億1517万-3.19%
08/09567572560569+0.35%255,600369億6047万-4.69%
08/08580580567567-2.07%223,700368億3056万-5.34%
08/07568579565579+1.22%257,900376億1004万-3.5%
08/04564573555572+0.88%375,200371億5534万-4.98%
08/03598599567567-5.97%867,600368億3056万-6.13%
08/02610616602603-1.95%333,600391億6901万-0.5%
08/01600625600615+2.5%674,400399億4849万+1.32%
07/31603609595600+0.67%226,000389億7414万-1.48%
07/28605605585596-1.65%565,600387億1431万-2.45%
07/27616625602606-2.1%283,700393億6388万-1.3%
07/26605621605619+1.81%397,400402億832万+0.32%
07/25595609592608+2.88%388,000394億9379万-1.78%
07/24592595586591-0.17%435,800383億8952万-4.83%
07/21595602590592-1.17%260,400383億8924万-4.98%
07/20601607595599-0.99%175,100388億4317万-4.01%
07/19600605592605+0.5%262,500392億3225万-3.66%
07/18603607598602+0.33%337,500390億3771万-4.75%
07/14596611596600+0.67%338,700389億802万-5.66%
07/13587598568596+1.02%751,500386億4863万-6.73%
07/12595602590590-1.34%410,000382億5955万-8.24%
07/11603604595598-2.29%625,800387億7832万-7.57%
07/1015:00 海外連結子会社における人員削減等の合理化に関するお知らせ
07/10605616605612+0.33%293,000396億8618万-5.85%
07/07601612599610+0.66%342,700395億5648万-6.58%
07/06612614601606-1.3%420,500392億9710万-7.62%
07/05615616608614-0.32%284,800398億1587万-6.69%
07/046126166066160%282,500399億4556万-6.67%
07/0316:30 行使価額修正条項付新株予約権の月間行使状況に関するお知らせ
07/03614620608616+0.65%309,600399億4556万-6.95%
06/30620622611612-1.29%376,200396億8618万-7.83%
06/29630630616620-1.59%372,100402億495万-6.63%
06/28633635622630-0.47%327,300408億5342万-5.26%
06/27638642629633-2.31%335,700410億4796万-5.1%
06/26647656638648-1.22%227,800420億2066万-2.99%
06/23672674649656-1.65%269,500425億3943万-1.65%
06/22676680662667-1.33%292,000432億5275万+0.15%
06/21681685671676-0.73%347,800438億3610万+1.96%
06/20662684648681+3.18%669,500441億6033万+3.18%
06/19638677630660+2.96%874,400427億9855万+0.46%
06/16620652620641+5.25%1,121,700415億6647万-2.14%
06/15665667605609-13%1,937,600394億9139万-6.88%
06/1415:00 営業外収益、特別利益及び法人税等調整額の計上に関するお知らせ
06/1415:00 国内SB623慢性期外傷性脳損傷プログラム製造販売承認取得の状況について(続報)
06/1415:00 2024年1月期第1四半期決算短信〔日本基準〕(連結)
06/14703704685700-0.71%564,200453億9241万+6.87%